SBC Medical Group Holdings Inc
NASDAQ:SBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SBC Medical Group Holdings Inc
NASDAQ:SBC
|
US |
|
Argeo AS
F:8W2
|
NO |
|
B
|
Bottomline Technologies Inc
F:BOT
|
US |
|
C3 Metals Inc
XTSX:CCCM
|
CA |
|
R
|
Rizal Commercial Banking Corp
XPHS:RCB
|
PH |
|
Dongyang Steel Pipe Co Ltd
KRX:008970
|
KR |
|
Wartsila Oyj Abp
OTC:WRTBF
|
FI |
|
Brooge Energy Ltd
NASDAQ:BROG
|
UK |
|
Guoco Group Ltd
HKEX:53
|
HK |
|
B
|
Blackhawk Growth Corp
CNSX:BLR
|
CA |
|
TomTom NV
AEX:TOM2
|
NL |
|
D
|
DOD Biotech PCL
SET:DOD
|
TH |
|
Linamar Corp
TSX:LNR
|
CA |
Wall Street
Price Targets
SBC Price Targets Summary
SBC Medical Group Holdings Inc
According to Wall Street analysts, the average 1-year price target for
SBC
is 8.29 USD
with a low forecast of 6.57 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SBC's stock price target?
Price Target
8.29
USD
According to Wall Street analysts, the average 1-year price target for
SBC
is 8.29 USD
with a low forecast of 6.57 USD and a high forecast of 9.45 USD.
What is SBC Medical Group Holdings Inc's Revenue forecast?
Projected CAGR
5%
The
compound annual growth rate
of
SBC Medical Group Holdings Inc's revenue for the next 3 years is
5%.
What is SBC Medical Group Holdings Inc's Operating Income forecast?
Projected CAGR
10%
The
compound annual growth rate
of
SBC Medical Group Holdings Inc's operating income for the next 2 years is
10%.
What is SBC Medical Group Holdings Inc's Net Income forecast?
Projected CAGR
9%
For the last 3 years the
compound annual growth rate for
SBC Medical Group Holdings Inc's net income is
353%.
The projected
CAGR
for the next 2 years is
9%.